BPC-157's regulatory status is complex and may vary by use, jurisdiction, and product category, including FDA regulatory and safety concerns regarding certain BPC-157-related bulk substances used in compounding contexts
It also has been found to aid in weight loss, making it a valuable medication for people struggling with obesity
22 It is a strategy that has capitalized on cumbersome FDA approval processes for early-stage clinical research, which shifted many phase I clinical trials abroad, mostly to China
Other players, such as EMS and Eurofarma, are also positioning themselves to enter the GLP-1 analogs market, which generated over R$3 billion (approximately $541 million USD) in Brazil from September 2023 to September 2024, according to IQVIA data
Weight loss varies by drug and dosetypically 5-10% with diabetes doses and potentially 15-20% with higher weight management doses over 68 weeks